Curestone Partners Platform Pte. Limited – Research Analyst

CureStone Partners Platform Pte. Limited engages in procuring, incubating, developing and commercializing bio-technologies in a holding company structure (“CureStone Platform” or “Platform”) with focus on rare, pediatric and repurposed drugs, neurodegenerative disorders and innovative technologies for targeted indications.  CureStone Platform currently owns a number of portfolio companies under its control and will continuously establish such portfolio companies (the “Portfolio Companies”);

Not all drug development is the same. Our approach is very unique in that we try to bring technologies that are easy and quick to commercialize, patient-friendly, highly unmet and leading to a dominant position in competition. Furthermore, our business model allows us to, firstly use minimal amount of capital in a highly efficient manner to reach milestones and, secondly create substantive inflection points at early phases which will reflect on significant economic values.

We also actively look to bring transformational changes to some of our prospective partners by licensing or co-developing our assets in an interest-aligned manner to create additional corporate values outside of our Portfolio Companies.